Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

Clinical trial NCT04802863 · COMPLETED

Trial details

NCT number: NCT04802863
Sponsor: Evopoint Biosciences Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2021-03-25
Primary completion: 2021-05-15
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.